QBQuoc Bui

Quoc Bui

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Quoc Bui has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Real-Time Associations Between Subjective Cognitive Concerns and Daily Activity Participation in Persons Aging With Stroke: Smartphone-Based Ecological Momentary Assessment Study

    by Jiali He, Quoc Bui, Mandy W M Fong, David C Mohr, Christopher L Metts, Alex W K Wong

    Background: Stroke is a leading cause of global disability in the aging population, with cognitive impairments playing a significant role. Prior research has shown that subjective cognitive concerns (SCCs) can predict later dementia and serve as an essential indicator for poststroke functional rehabilitation. The use of smartphone-based ecological momentary assessment (EMA) in real-world environments may help us understand how SCCs relate to daily functioning in individuals aging with stroke, thereby guiding cognitive rehabilitation and prevention efforts. Objective: Our study aimed to use EMA to examine the real-time associations between SCCs and daily activity participation in persons aging with stroke. Methods: This longitudinal observational study used smartphone-based EMA for real-time assessment of individual cognitive concerns and participation in various daily activities. EMA survey items, including SCCs (concentration and learning) and participation in daily activities (location, company, current activity, and self-appraisals of performance, help needed, satisfaction, and engagement), were collected 5 times per day for 2 weeks. Multilevel models were used to analyze the data. Results: A total of 202 individuals with mild-to-moderate chronic stroke participated in the study (n=90, 44.6% female; n=89, 44.1% Black; n=182, 90.1% ischemic stroke; mean age 59.7, SD 11.7 years). SCCs were concurrently lower when participants engaged in activities of daily living (ADL; B=−0.04, 95% CI −0.07 to −0.01; P =.02), instrumental ADL (B=−0.05, 95% CI −0.07 to −0.02; P <.001), cognitively stimulating activities (B=−0.05, 95% CI −0.08 to −0.02; P <.001), and social activities (B=−0.05, 95% CI −0.08 to −0.02; P =.002); when participants were located in a friend’s home (B=−0.10, 95% CI −0.17 to −0.02; P =.001); and when they spent time with family members (B=−0.07, 95% CI −0.10 to −0.04; P <.001), friends (B=−0.05, 95% CI −0.10 to −0.01; P =.01), and spouse or partners (B=−0.04, 95% CI −0.07 to −0.01; P =.02). Conversely, SCCs were higher when participants were in the hospital (B=0.39, 95% CI 0.25‐0.53; P <.001). Additionally, greater SCCs were concurrently associated with worse ratings of performance (B=−0.05, 95% CI −0.06 to −0.05; P <.001), satisfaction (B=−0.05, 95% CI −0.06 to −0.05; P <.001), and activity engagement (B=−0.05, 95% CI −0.06 to −0.04; P <.001). Conclusions: EMA provides an effective means of understanding the links between poststroke cognition and participation in daily activities. Our findings suggest that ADL, instrumental ADL, cognitively demanding activities, and socially engaging activities may lessen cognitive concerns among stroke survivors, implying that clinicians should schedule these activities to help reduce poststroke cognitive issues. Conversely, interventions that enhance cognition may increase participation in these challenging activities. Tracking cognition, everyday activity involvement, and their interactions in real-world settings could ultimately help develop rehabilitation and prevention strategies for individuals at risk of dementia due to stroke.

  • Open Access

    Valve involvement in infective endocarditis among intravenous drug users: a systematic review and meta-analysis

    by Minh H. N. Le, Hung H. Phan, Vien T. Truong, Minh P. Tang, Phat K. Nguyen, An Thuy Vo, Loc T. Vu, Duy Chung, Chi N. Duong, Quoc Bui, et al.

    Background: Intravenous drug use (IVDU) is a major risk factor for infective endocarditis (IE), with right-sided infective endocarditis (RSIE) most frequently observed. However, precise estimates of valve involvement and the relative risk (RR) of RSIE within the IVDU population remain unclear. This systematic review and meta-analysis aimed to quantify the prevalence of RSIE, left-sided IE (LSIE), both-sided IE, and valve-specific involvement in IVDUs while assessing the relative risk of right-sided versus left-sided IE within the IVDU population. Methods: A systematic search was conducted in PubMed, Embase, and Web of Science to identify studies reporting IE in IVDUs. Inclusion criteria followed the PICO framework, ensuring clear definitions of IVDU status and valve involvement. A random-effects model was used to calculate pooled prevalence estimates and RR ratios with 95% confidence intervals (CIs). Heterogeneity was assessed using the I² statistic, and sensitivity analyses were performed. Results: A total of 14 studies involving 1,783 patients met the inclusion criteria. The pooled prevalence of right-sided infective endocarditis (RSIE) was 59% (95% CI: 54%–65%), left-sided infective endocarditis (LSIE) was 39% (95% CI: 33%–46%), and both-sided infective endocarditis was 8% (95% CI: 6%–12%). Among individual valves, the tricuspid valve was most commonly affected (59% (95% CI: 53%–64%)), followed by the mitral valve (21% (95% CI: 18%–26%)) and the aortic valve (16% (95% CI: 12%–20%)). Pulmonic valve involvement was rare (1% (95% CI: 0%–3%)). Overall, individuals who inject drugs (IVDUs) had a 1.49-fold increased risk of developing right-sided IE compared to left-sided IE (RR = 1.49 (95% CI: 1.15–1.95), p = 0.008). Conclusion: This SRMA confirms the predominance of right-sided IE, particularly tricuspid valve involvement, in IVDUs, with a significantly higher risk compared to left-sided IE. The findings underscore the need for targeted screening, early intervention, and IVDU-specific management strategies in IE care. Future research should focus on regional variations, microbiological patterns, and long-term outcomes in this high-risk population. Clinical trial number: Not applicable.

  • Protective predictors of cardiovascular disease: an explainable AI approach

    by Minh H. N. Le, Hien Quang Kha, Han H. Huynh, Phat K. Huynh, Phat Ky Nguyen, Dang Nguyen, Trang D. T. Le, Nghi V. Tran, Quoc Bui, Hoang Tran Pham, et al.


  • Satisfaction, user experiences, and initial efficacy of a technology-supported self-management intervention (iSMART) to improve post-stroke functioning: a remoted randomized controlled trial

    by Yating Lei, Zhaoying Li, Quoc Bui, Olivia DePaul, Ginger E. Nicol, David C. Mohr, Mandy W. M. Fong, Christopher L. Metts, Sunghoon I. Lee, Stephanie E. Tomazin, et al.

    Self-management interventions empower individuals to manage their chronic conditions and daily life after stroke. However, traditional in-person self-management interventions often face transportation and geographical barriers. Digital interventions may offer a solution to address this gap. This pilot randomized controlled trial (RCT) aimed to examine treatment satisfaction, user experiences, and the initial effect of the interactive Self-Management Augmented by Rehabilitation Technologies (iSMART) intervention in stroke survivors to improve post-stroke functioning. Participants (N = 24) with mild-to-moderate chronic stroke completed a parallel, 2-arm, nonblinded, remote RCT. They were randomly assigned to either a 12-week iSMART or a control intervention (post-stroke information). iSMART was a technology-based self-management intervention involving skill-building education, human coaching, and text messaging. Participants completed a battery measuring treatment satisfaction, use experiences, and function and participation outcomes at baseline and post-intervention. iSMART participants expressed greater satisfaction with their treatment (r = 0.387), healthcare environment (r = 0.454), relationships with providers (r = 0.374), and higher expectations for positive treatment outcomes (r = 0.328) than control participants, with medium effect sizes. The iSMART group rated the overall program and its coaching, skill-building, and text messaging components as helpful. iSMART participants showed a medium effect in improving overall post-stroke functioning, but control participants showed a small effect. Moreover, iSMART participants showed moderate-to-large effects in improving hand function (r = 0.699), mobility (r = 0.499), memory and thinking (r = 0.436), communication (r = 0.416), social participation (r = 0.307), community reintegration (r = 0.652), and perceived recovery (r = 0.545). Our results provide initial evidence that iSMART supports stroke survivors in managing chronic conditions and enhancing post-stroke functioning.


  • Open Access

    Racial Disparities in Clinical Outcomes of Takotsubo Cardiomyopathy: An Analysis of the National Inpatient Sample 2006 to 2018

    by Chi N. Duong, Quoc V. P. Bui, Thomas Duong, Dai Q. Phan, Jan Mazur, Eugene Chung, Vien T. Truong

    Background: This study aimed to evaluate the impact of race on in‐hospital outcomes of Takotsubo cardiomyopathy using the National Inpatient Sample. Methods and Results: We conducted a retrospective study using data from the National Inpatient Sample database 2006 to 2018. We focused on Takotsubo cardiomyopathy hospitalizations, excluding those with acute coronary syndrome as the primary diagnosis. Two study groups consisted of White patients or Black patients. Univariate and multivariable logistic models evaluated race's effect on death, cardiac arrest, cardiogenic shock, length of stay, while adjusting for potential confounders. The Bayesian model averaging technique was used to further elucidate the factors influencing death within each racial group. Significant differences were observed between the 2 racial groups. Black patients presented at a younger age, had a higher proportion of men, a higher burden of comorbidities, and a lower median household income compared with their White counterparts. In the univariate model, the Black cohort showed an increased risk of cardiac arrest (odds ratio, 1.45 [95% CI, 1.15–1.82]). However, the difference did not reach statistical significance in the multivariable model. Black patients also had a significantly longer hospital stay in both the univariate model (risk ratio, 1.26 [95% CI, 1.22–1.31]) and the multivariable model (risk ratio, 1.06 [95% CI, 1.04–1.07]). No significant difference in all‐cause death was observed between the racial groups. Conclusions: The outcome differences between 2 racial groups in our study are likely influenced by racial disparities in demographics, comorbidities, and socioeconomic factors. Individualized care based on racial group needs is crucial in clinical practice.


  • Open Access

    A Digital Intervention to Promote Self-Management Self-Efficacy Among Community-Dwelling Individuals With Stroke: Pilot Randomized Controlled Trial

    by Zhaoying Li, Yating Lei, Quoc Bui, Olivia DePaul, Ginger E Nicol, David C Mohr, Sunghoon I Lee, Mandy W M Fong, Christopher L Metts, Stephanie E Tomazin, et al.

    Background: Digital interventions provided through smartphones or the internet that are guided by a coach have been proposed as promising solutions to support the self-management of chronic conditions. However, digital intervention for poststroke self-management is limited; we developed the interactive Self-Management Augmented by Rehabilitation Technologies (iSMART) intervention to address this gap. Objective: This study aimed to examine the feasibility and initial effects of the iSMART intervention to improve self-management self-efficacy in people with stroke. Methods: A parallel, 2-arm, nonblinded, randomized controlled trial of 12-week duration was conducted. A total of 24 participants with mild-to-moderate chronic stroke were randomized to receive either the iSMART intervention or a manual of stroke rehabilitation (attention control). iSMART was a coach-guided, technology-supported self-management intervention designed to support people managing chronic conditions and maintaining active participation in daily life after stroke. Feasibility measures included retention and engagement rates in the iSMART group. For both the iSMART intervention and active control groups, we used the Feasibility of Intervention Measure, Acceptability of Intervention Measure, and Intervention Appropriateness Measure to assess the feasibility, acceptability, and appropriateness, respectively. Health measures included the Participation Strategies Self-Efficacy Scale and the Patient-Reported Outcomes Measurement Information System’s Self-Efficacy for Managing Chronic Conditions. Results: The retention rate was 82% (9/11), and the engagement (SMS text message response) rate was 78% for the iSMART group. Mean scores of the Feasibility of Intervention Measure, Acceptability of Intervention Measure, and Intervention Appropriateness Measure were 4.11 (SD 0.61), 4.44 (SD 0.73), and 4.36 (SD 0.70), respectively, which exceeded our benchmark (4 out of 5), suggesting high feasibility, acceptability, and appropriateness of iSMART. The iSMART group showed moderate-to-large effects in improving self-efficacy in managing emotions (r=0.494), symptoms (r=0.514), daily activities (r=0.593), and treatments and medications (r=0.870), but the control group showed negligible-to-small effects in decreasing self-efficacy in managing emotions (r=0.252), symptoms (r=0.262), daily activities (r=0.136), and treatments and medications (r=0.049). In addition, the iSMART group showed moderate-to-large effects of increasing the use of participation strategies for management in the home (r=0.554), work (r=0.633), community (r=0.673), and communication activities (r=0.476). In contrast, the control group showed small-to-large effects of decreasing the use of participation strategies for management in the home (r=0.567), work (r=0.342, community (r=0.215), and communication activities (r=0.379). Conclusions: Our findings support the idea that iSMART was feasible to improve poststroke self-management self-efficacy. Our results also support using a low-cost solution, such as SMS text messaging, to supplement traditional therapeutic patient education interventions. Further evaluation with a larger sample of participants is still needed. Trial Registration: ClinicalTrials.gov 202004137; https://clinicaltrials.gov/study/NCT04743037?id=202004137&rank=1


  • Open Access

    A Digital Intervention to Promote Self-Management Self-Efficacy Among Community-Dwelling Individuals With Stroke: Pilot Randomized Controlled Trial (Preprint)

    by Zhaoying Li, Yating Lei, Quoc Bui, Olivia DePaul, Ginger E Nicol, David C Mohr, Sunghoon I Lee, Mandy W M Fong, Christopher L Metts, Stephanie E Tomazin, et al.

    BACKGROUND Digital interventions provided through smartphones or the internet that are guided by a coach have been proposed as promising solutions to support the self-management of chronic conditions. However, digital intervention for poststroke self-management is limited; we developed the interactive Self-Management Augmented by Rehabilitation Technologies (iSMART) intervention to address this gap. OBJECTIVE This study aimed to examine the feasibility and initial effects of the iSMART intervention to improve self-management self-efficacy in people with stroke. METHODS A parallel, 2-arm, nonblinded, randomized controlled trial of 12-week duration was conducted. A total of 24 participants with mild-to-moderate chronic stroke were randomized to receive either the iSMART intervention or a manual of stroke rehabilitation (attention control). iSMART was a coach-guided, technology-supported self-management intervention designed to support people managing chronic conditions and maintaining active participation in daily life after stroke. Feasibility measures included retention and engagement rates in the iSMART group. For both the iSMART intervention and active control groups, we used the Feasibility of Intervention Measure, Acceptability of Intervention Measure, and Intervention Appropriateness Measure to assess the feasibility, acceptability, and appropriateness, respectively. Health measures included the Participation Strategies Self-Efficacy Scale and the Patient-Reported Outcomes Measurement Information System’s Self-Efficacy for Managing Chronic Conditions. RESULTS The retention rate was 82% (9/11), and the engagement (SMS text message response) rate was 78% for the iSMART group. Mean scores of the Feasibility of Intervention Measure, Acceptability of Intervention Measure, and Intervention Appropriateness Measure were 4.11 (SD 0.61), 4.44 (SD 0.73), and 4.36 (SD 0.70), respectively, which exceeded our benchmark (4 out of 5), suggesting high feasibility, acceptability, and appropriateness of iSMART. The iSMART group showed moderate-to-large effects in improving self-efficacy in managing emotions (r=0.494), symptoms (r=0.514), daily activities (r=0.593), and treatments and medications (r=0.870), but the control group showed negligible-to-small effects in decreasing self-efficacy in managing emotions (r=0.252), symptoms (r=0.262), daily activities (r=0.136), and treatments and medications (r=0.049). In addition, the iSMART group showed moderate-to-large effects of increasing the use of participation strategies for management in the home (r=0.554), work (r=0.633), community (r=0.673), and communication activities (r=0.476). In contrast, the control group showed small-to-large effects of decreasing the use of participation strategies for management in the home (r=0.567), work (r=0.342, community (r=0.215), and communication activities (r=0.379). CONCLUSIONS Our findings support the idea that iSMART was feasible to improve poststroke self-management self-efficacy. Our results also support using a low-cost solution, such as SMS text messaging, to supplement traditional therapeutic patient education interventions. Further evaluation with a larger sample of participants is still needed. CLINICALTRIAL ClinicalTrials.gov 202004137; https://clinicaltrials.gov/study/NCT04743037?id=202004137&rank=1

  • Sun protective behaviors among adolescents and young adults in the United States

    by Sai D Challapalli, Kunal R Shetty, Quoc Bui, Nosayaba Osazuwa-Peters, Eric Adjei Boakye


  • Open Access

    Smartphone-Based Ecological Momentary Assessment as the New Standard Measure for Post-Stroke Functioning (Preprint)

    by Quoc Bui, Katherine J. Kaufman, Vy Pham, Eric J. Lenze, Jin-Moo Lee, David C. Mohr, Mandy W.M. Fong, Christopher L. Metts, Stephanie E. Tomazin, Alex W.K. Wong

    BACKGROUND Functional disability is common after stroke. To inform new treatments, better measures are needed to advance our understanding of post-stroke functioning. Ecological momentary assessment (EMA) provides a putatively valid measure of everyday functioning by assessing patients during their lived experiences. OBJECTIVE This study aims to validate the smartphone-based EMA to characterize post-stroke everyday functioning and symptoms. METHODS Participants (N=212) with mild to moderate stroke were assessed five times daily for 14 days with EMA surveys to appraise mental, somatic, and cognitive symptoms, and what, with whom, and where participants were doing activities. Participants also completed standardized assessments during lab visits. RESULTS Most participants (median age = 60 years) were ischemic stroke (90%) and neurologically mild (median NIHSS = 2). Total 14,140 EMA surveys were analyzed. Participants were home 78% of the time and primarily participated in passive, unproductive activities, especially watching television and resting. EMA was sensitive to indicators of post-stroke disability; unemployed participants reported fewer vocational activities (W =12183.5, P < .001) but more activities of daily living (ADL) (W =6995, P < .001) and passive activities (W =7499.5, P =.003) than employed counterparts. Users of mobility devices and participants with cognitive problems spent significantly less time on vocational activities (W =2717, P< .0001 for mobility devices; W =7278, P= .03 for cognitive problems) and more on ADL (W =4807.5, P= .010 for mobility devices; W =9516.5, P< .001 for cognitive problems) than non-users and those without cognitive problems. Our data supported the validity of EMA methods in stroke, with small-to-moderate correlations of EMA with in-lab measures of daily functioning and very large correlations between EMA and in-lab measures of symptoms, especially those measuring the same constructs. CONCLUSIONS Our findings reveal that EMA tracked post-stroke functioning precisely. EMA may be beneficial in examining post-stroke functional recovery, monitoring patients for home-based interventions, and for longitudinal research. CLINICALTRIAL NA

  • Open Access

    Long‐term outcomes of primary cardiac malignant tumors: Difference between African American and Caucasian population

    by Quoc Bui, Tam N. M. Ngo, Jan Mazur, Vy Pham, Cassady Palmer, Binh Q. Truong, Eugene S. Chung, Huy G. Vuong, Vien T. Truong

    Background: The survival outcome for primary cardiac malignant tumors (PMCTs) based on race has yet to be fully elucidated in previously published literature. This study aimed to address the general long‐term outcome and survival rate differences in PMCTs among African Americans and Caucasian populations.Methods: The 18 cancer registries database from the Surveillance, Epidemiology, and End Results (SEER) Program from 1975 to 2016 were utilized. Ninety‐four African American (AA) and 647 Caucasian (CAU) patients from the SEER registry were available for survival analysis. The log‐rank test was used to compare the difference in mortality between two populations and presented by the Kaplan–Meier curves. A multivariate Cox proportional hazards regression was used to determine the independent predictors of all‐cause mortality.Results: The overall 30‐day, 1‐year, and 5‐year survival rates were 74%, 44.3%, and 16.6%, respectively, with a median survival of 10 months. There was no significant difference in survival rate between the two races (p‐value = 0.55). The 1‐year survival rate improved significantly during the study timeline in the AA population (13.3% during 1975–1998, 40.9% during 1999–2004, 50% during 2005–2010, and 59.7% during 2011–2016, p‐value = 0.0064). Age of diagnosis, type of tumor, disease stage, and chemotherapy administration are the main factors that predict survival outcomes of PMCT patients. Interactive nomogram was developed based on significant predictors.Conclusions: PMCTs have remained one of the most lethal diseases with poor survival outcome. Survival rate improved during the timeline in AA patients, but in general, racial differences in survival outcome were not observed.